12:00 AM
Oct 29, 2015
 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Interleukin-9 (IL-9); (FCER1A)



Mouse studies suggest inhibiting the production of IL-9-producing mucosal mast cells (MMC9s) could help treat IgE-mediated food allergy. In a mouse model of food allergy, intragastric ovalbumin challenge increased numbers of intestinal...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >